{"id":16346,"date":"2022-07-31T00:00:00","date_gmt":"2022-07-31T04:00:00","guid":{"rendered":"https:\/\/livingstagenew.wpenginepowered.com\/transaction\/livingstone-secures-corporate-vc-investment-from-ngk-spark-plug-for-medtech-innovation-leader-in-cold-plasma-technology-neoplas-med\/"},"modified":"2026-06-25T10:08:52","modified_gmt":"2026-06-25T14:08:52","slug":"livingstone-secures-corporate-vc-investment-from-ngk-spark-plug-for-medtech-innovation-leader-in-cold-plasma-technology-neoplas-med","status":"publish","type":"transaction","link":"https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-secures-corporate-vc-investment-from-ngk-spark-plug-for-medtech-innovation-leader-in-cold-plasma-technology-neoplas-med\/","title":{"rendered":"Livingstone asesora a neoplas med en su refinanciaci\u00f3n estrat\u00e9gica por parte de NGK Spark Plug."},"content":{"rendered":"\n<p>El equipo de Healthcare de Livingstone ha asesorado a <a href=\"https:\/\/neoplas-med.eu\/en\/\">neoplas med GmbH<\/a>, l\u00edder en innovaci\u00f3n en tecnolog\u00eda de plasma fr\u00edo para el sector m\u00e9dico y veterinario, en su ronda de financiaci\u00f3n A a trav\u00e9s de <a href=\"https:\/\/www.pegasustechventures.com\/\">Pegasus Tech Ventures<\/a>, actuando como Fund Manager de <a href=\"https:\/\/www.ngkntk.co.jp\/english\/\">NGK Spark Plug Co. Ltd<\/a>. (&#8220;NGK&#8221;). La inversi\u00f3n forma parte del programa de innovaci\u00f3n llevado a cabo por NGK Venture Lab.<\/p>\n<p>neoplas med GmbH se fund\u00f3 en 2009 como una escisi\u00f3n del Instituto Leibniz de Investigaci\u00f3n y Tecnolog\u00eda del Plasma (INP) de Greifswald. Ulrike Sailer es la directora general desde finales de 2019. La empresa desarrolla productos innovadores para aplicaciones m\u00e9dicas basados en la investigaci\u00f3n m\u00e9dica del plasma. El primer hito fue el chorro de plasma kINPen\u00ae MED, con certificaci\u00f3n CE, que es el primer chorro de plasma del mundo aprobado para el tratamiento de heridas cr\u00f3nicas y enfermedades de la piel relacionadas con pat\u00f3genos y se comercializa a nivel internacional. La tecnolog\u00eda de precisi\u00f3n fue desarrollada por el INP como incubadora en cooperaci\u00f3n con el Centro M\u00e9dico Universitario de Greifswald, la Klinikum Karlsburg y la Charit\u00e9 de Berl\u00edn, as\u00ed como con otros socios de la industria cient\u00edfica y neoplas med con el desarrollo y producci\u00f3n de plasma m\u00e9dico orientado a las necesidades de los pacientes.<\/p>\n<p>Es el dispositivo m\u00e1s estudiado y mejor caracterizado a nivel mundial para el tratamiento con plasma de heridas infectadas y cr\u00f3nicas. El dispositivo de plasma fr\u00edo kINPen es el primer dispositivo que funciona sin contacto con una alta y constante calidad, lo que ha sido verificado por dos estudios cl\u00ednicos RCT publicados en las prestigiosas revistas JAMA Network Open y Nature Scientific Report.<\/p>\n<p>NGK SPARK PLUG CO., LTD. con sede en Nagoya, Jap\u00f3n, es un fabricante de productos cer\u00e1micos y dispositivos relacionados. La empresa es l\u00edder mundial en la producci\u00f3n de buj\u00edas y sensores de automoci\u00f3n para motores de combusti\u00f3n interna y ofrece una amplia gama de componentes para equipos de producci\u00f3n de semiconductores, herramientas de corte y cer\u00e1mica industrial bajo la marca NTK. Una red global de organizaciones de ventas y producci\u00f3n y m\u00e1s de 16.000 empleados garantizan la puesta en valor en todo el mundo. La empresa contribuye a una sociedad sostenible desarrollando productos para el medio ambiente, la energ\u00eda, los veh\u00edculos de nueva generaci\u00f3n y los dispositivos m\u00e9dicos y de diagn\u00f3stico. Como fabricante l\u00edder, NGK SPARK PLUG ofrece soluciones innovadoras para mejorar nuestro mundo. NGK ha desarrollado tecnolog\u00edas de plasma en las 3 \u00e1reas de crecimiento: Salud, Servicios P\u00fablicos y Movilidad. La empresa tiene la intenci\u00f3n de hacer crecer los negocios de Plasma para el Cuidado de la Salud en el mercado de los dispositivos de plasma fr\u00edo. Junto con la innovadora tecnolog\u00eda (de vanguardia) de plasma fr\u00edo de neoplas med, NGK quiere convertirse en un actor principal en el mercado m\u00e9dico y veterinario.<\/p>\n<p>Las partes est\u00e1n convencidas de haber acordado una cooperaci\u00f3n estrat\u00e9gica muy fruct\u00edfera con un importante potencial de crecimiento, as\u00ed como grandes beneficios para todos los pacientes que utilizan los dispositivos de plasma fr\u00edo.<\/p>\n<p>Pegasus Tech Ventures act\u00faa como gestor de fondos de capital riesgo para NGK. Pegasus es una empresa global de capital riesgo con sede en Silicon Valley. Este gestor trabaja con m\u00e1s de 30 corporaciones multinacionales, como NGK, para acelerar sus estrategias de innovaci\u00f3n gestionando fondos de capital riesgo corporativo en su nombre y conect\u00e1ndolos con startups que tienen un valor estrat\u00e9gico significativo, como neoplas med.<\/p>\n<p>Dirk Schapeler, Presidente de la Divisi\u00f3n de Creaci\u00f3n de Negocios de NGK, comenta: <strong>\u00abEn el &#8220;Plan de gesti\u00f3n a largo plazo &#8220;2030 Nittoku BX&#8221;, nos hemos propuesto la transformaci\u00f3n de la cartera de negocios para aumentar la proporci\u00f3n del negocio de los motores de combusti\u00f3n no interna, y como una de las medidas para realizarlo, estamos promoviendo la creaci\u00f3n de nuevos negocios en el \u00e1rea de &#8220;Smart Health&#8221;, &#8220;Decentralized Utilities&#8221; y &#8220;Smart Mobility&#8221;. En ese esfuerzo, en el \u00e1rea de &#8220;Smart Health&#8221;, estamos trabajando en el cuidado de heridas que aplica nuestra tecnolog\u00eda de plasma m\u00e9dico y colaboraremos con neoplas med para acelerar su desarrollo empresarial\u00bb.<\/strong><\/p>\n<p>Ulrike Sailer, CEO de neoplas med GmbH, se\u00f1ala: <strong>\u00abJunto con Livingstone Partners hemos podido encontrar un socio estrat\u00e9gico que nos ayudar\u00e1 a desarrollar las aplicaciones de nuestra tecnolog\u00eda de chorro de plasma fr\u00edo para las necesidades de los pacientes y a entrar en nuevos mercados extranjeros. Me gustar\u00eda dar las gracias a Livingstone y a los doctores J\u00f6rn-Christian Schulze y Severin Steffens de Arqis Rechtsanw\u00e4lte, as\u00ed como a todas las dem\u00e1s partes implicadas por el buen desarrollo del proceso\u00bb.<\/strong><\/p>\n<p>El <a href=\"https:\/\/livingstonepartners.com\/es\/team\/dr-ralf-nowak\/\">Dr. Ralf Nowak<\/a>, Director General de Livingstone en D\u00fcsseldorf, comenta: <strong>\u00abEstamos muy contentos de haber encontrado el socio estrat\u00e9gico m\u00e1s adecuado para <em>neoplas med<\/em>. La fuerza innovadora de <em>neoplas med<\/em> y la probada tecnolog\u00eda de plasma fr\u00edo, combinadas con la excelente experiencia de NGK en materia de plasma y atenci\u00f3n sanitaria y la amplia red internacional de NGK, impulsar\u00e1n esta historia de \u00e9xito.\u00bb<\/strong><\/p>\n<p>Los t\u00e9rminos de la transacci\u00f3n no se han hecho p\u00fablicos.<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":3844,"template":"","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"client-type":[],"region":[],"sector":[],"service":[],"transaction-type":[],"class_list":["post-16346","transaction","type-transaction","status-publish","has-post-thumbnail","hentry"],"acf":{"team_members":[1773,1801],"date":"20220731","client_type":46,"type":[1035],"region":[396,1219],"services":[464],"sectors":[843,852],"related_transactions":"","related_testimonials":[52923],"contacts":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Livingstone asesora a neoplas med en su refinanciaci\u00f3n estrat\u00e9gica por parte de NGK Spark Plug. - Livingstone Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-secures-corporate-vc-investment-from-ngk-spark-plug-for-medtech-innovation-leader-in-cold-plasma-technology-neoplas-med\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Livingstone asesora a neoplas med en su refinanciaci\u00f3n estrat\u00e9gica por parte de NGK Spark Plug. - Livingstone Partners\" \/>\n<meta property=\"og:url\" content=\"https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-secures-corporate-vc-investment-from-ngk-spark-plug-for-medtech-innovation-leader-in-cold-plasma-technology-neoplas-med\/\" \/>\n<meta property=\"og:site_name\" content=\"Livingstone Partners\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-25T14:08:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/livingstonepartners.com\/wp-content\/uploads\/2026\/05\/41d86122.png\" \/>\n\t<meta property=\"og:image:width\" content=\"550\" \/>\n\t<meta property=\"og:image:height\" content=\"316\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/transaction\\\/livingstone-secures-corporate-vc-investment-from-ngk-spark-plug-for-medtech-innovation-leader-in-cold-plasma-technology-neoplas-med\\\/\",\"url\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/transaction\\\/livingstone-secures-corporate-vc-investment-from-ngk-spark-plug-for-medtech-innovation-leader-in-cold-plasma-technology-neoplas-med\\\/\",\"name\":\"Livingstone asesora a neoplas med en su refinanciaci\u00f3n estrat\u00e9gica por parte de NGK Spark Plug. - Livingstone Partners\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/transaction\\\/livingstone-secures-corporate-vc-investment-from-ngk-spark-plug-for-medtech-innovation-leader-in-cold-plasma-technology-neoplas-med\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/transaction\\\/livingstone-secures-corporate-vc-investment-from-ngk-spark-plug-for-medtech-innovation-leader-in-cold-plasma-technology-neoplas-med\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/livingstonepartners.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/41d86122.png\",\"datePublished\":\"2022-07-31T04:00:00+00:00\",\"dateModified\":\"2026-06-25T14:08:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/transaction\\\/livingstone-secures-corporate-vc-investment-from-ngk-spark-plug-for-medtech-innovation-leader-in-cold-plasma-technology-neoplas-med\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/transaction\\\/livingstone-secures-corporate-vc-investment-from-ngk-spark-plug-for-medtech-innovation-leader-in-cold-plasma-technology-neoplas-med\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/transaction\\\/livingstone-secures-corporate-vc-investment-from-ngk-spark-plug-for-medtech-innovation-leader-in-cold-plasma-technology-neoplas-med\\\/#primaryimage\",\"url\":\"https:\\\/\\\/livingstonepartners.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/41d86122.png\",\"contentUrl\":\"https:\\\/\\\/livingstonepartners.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/41d86122.png\",\"width\":550,\"height\":316},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/transaction\\\/livingstone-secures-corporate-vc-investment-from-ngk-spark-plug-for-medtech-innovation-leader-in-cold-plasma-technology-neoplas-med\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Homepage\",\"item\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Transactions\",\"item\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/transaction\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Livingstone asesora a neoplas med en su refinanciaci\u00f3n estrat\u00e9gica por parte de NGK Spark Plug.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/\",\"name\":\"Livingstone Partners\",\"description\":\"Deals Done Right.\",\"publisher\":{\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/#organization\",\"name\":\"Livingstone Partners\",\"url\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/livingstonepartners.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/logo_livingstone.svg\",\"contentUrl\":\"https:\\\/\\\/livingstonepartners.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/logo_livingstone.svg\",\"caption\":\"Livingstone Partners\"},\"image\":{\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Livingstone asesora a neoplas med en su refinanciaci\u00f3n estrat\u00e9gica por parte de NGK Spark Plug. - Livingstone Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-secures-corporate-vc-investment-from-ngk-spark-plug-for-medtech-innovation-leader-in-cold-plasma-technology-neoplas-med\/","og_locale":"es_ES","og_type":"article","og_title":"Livingstone asesora a neoplas med en su refinanciaci\u00f3n estrat\u00e9gica por parte de NGK Spark Plug. - Livingstone Partners","og_url":"https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-secures-corporate-vc-investment-from-ngk-spark-plug-for-medtech-innovation-leader-in-cold-plasma-technology-neoplas-med\/","og_site_name":"Livingstone Partners","article_modified_time":"2026-06-25T14:08:52+00:00","og_image":[{"width":550,"height":316,"url":"https:\/\/livingstonepartners.com\/wp-content\/uploads\/2026\/05\/41d86122.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-secures-corporate-vc-investment-from-ngk-spark-plug-for-medtech-innovation-leader-in-cold-plasma-technology-neoplas-med\/","url":"https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-secures-corporate-vc-investment-from-ngk-spark-plug-for-medtech-innovation-leader-in-cold-plasma-technology-neoplas-med\/","name":"Livingstone asesora a neoplas med en su refinanciaci\u00f3n estrat\u00e9gica por parte de NGK Spark Plug. - Livingstone Partners","isPartOf":{"@id":"https:\/\/livingstonepartners.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-secures-corporate-vc-investment-from-ngk-spark-plug-for-medtech-innovation-leader-in-cold-plasma-technology-neoplas-med\/#primaryimage"},"image":{"@id":"https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-secures-corporate-vc-investment-from-ngk-spark-plug-for-medtech-innovation-leader-in-cold-plasma-technology-neoplas-med\/#primaryimage"},"thumbnailUrl":"https:\/\/livingstonepartners.com\/wp-content\/uploads\/2026\/05\/41d86122.png","datePublished":"2022-07-31T04:00:00+00:00","dateModified":"2026-06-25T14:08:52+00:00","breadcrumb":{"@id":"https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-secures-corporate-vc-investment-from-ngk-spark-plug-for-medtech-innovation-leader-in-cold-plasma-technology-neoplas-med\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-secures-corporate-vc-investment-from-ngk-spark-plug-for-medtech-innovation-leader-in-cold-plasma-technology-neoplas-med\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-secures-corporate-vc-investment-from-ngk-spark-plug-for-medtech-innovation-leader-in-cold-plasma-technology-neoplas-med\/#primaryimage","url":"https:\/\/livingstonepartners.com\/wp-content\/uploads\/2026\/05\/41d86122.png","contentUrl":"https:\/\/livingstonepartners.com\/wp-content\/uploads\/2026\/05\/41d86122.png","width":550,"height":316},{"@type":"BreadcrumbList","@id":"https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-secures-corporate-vc-investment-from-ngk-spark-plug-for-medtech-innovation-leader-in-cold-plasma-technology-neoplas-med\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Homepage","item":"https:\/\/livingstonepartners.com\/es\/"},{"@type":"ListItem","position":2,"name":"Transactions","item":"https:\/\/livingstonepartners.com\/es\/transaction\/"},{"@type":"ListItem","position":3,"name":"Livingstone asesora a neoplas med en su refinanciaci\u00f3n estrat\u00e9gica por parte de NGK Spark Plug."}]},{"@type":"WebSite","@id":"https:\/\/livingstonepartners.com\/es\/#website","url":"https:\/\/livingstonepartners.com\/es\/","name":"Livingstone Partners","description":"Deals Done Right.","publisher":{"@id":"https:\/\/livingstonepartners.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/livingstonepartners.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/livingstonepartners.com\/es\/#organization","name":"Livingstone Partners","url":"https:\/\/livingstonepartners.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/livingstonepartners.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/livingstonepartners.com\/wp-content\/uploads\/2026\/05\/logo_livingstone.svg","contentUrl":"https:\/\/livingstonepartners.com\/wp-content\/uploads\/2026\/05\/logo_livingstone.svg","caption":"Livingstone Partners"},"image":{"@id":"https:\/\/livingstonepartners.com\/es\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/transaction\/16346","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/transaction"}],"about":[{"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/types\/transaction"}],"version-history":[{"count":1,"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/transaction\/16346\/revisions"}],"predecessor-version":[{"id":70065,"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/transaction\/16346\/revisions\/70065"}],"acf:post":[{"embeddable":true,"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/testimonial\/52923"},{"embeddable":true,"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/team-member\/1801"},{"embeddable":true,"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/team-member\/1773"}],"acf:term":[{"embeddable":true,"taxonomy":"sector","href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/sector\/852"},{"embeddable":true,"taxonomy":"sector","href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/sector\/843"},{"embeddable":true,"taxonomy":"service","href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/service\/464"},{"embeddable":true,"taxonomy":"region","href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/region\/1219"},{"embeddable":true,"taxonomy":"region","href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/region\/396"},{"embeddable":true,"taxonomy":"transaction-type","href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/transaction-type\/1035"},{"embeddable":true,"taxonomy":"client-type","href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/client-type\/46"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/media\/3844"}],"wp:attachment":[{"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/media?parent=16346"}],"wp:term":[{"taxonomy":"client-type","embeddable":true,"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/client-type?post=16346"},{"taxonomy":"region","embeddable":true,"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/region?post=16346"},{"taxonomy":"sector","embeddable":true,"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/sector?post=16346"},{"taxonomy":"service","embeddable":true,"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/service?post=16346"},{"taxonomy":"transaction-type","embeddable":true,"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/transaction-type?post=16346"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}